feed,title,long_url,short_url
SeekingAlpha,"Regeneron, Sanofi report mixed outcomes in late-stage trials for Dupixent",https://seekingalpha.com/news/4148609,
SeekingAlpha,Harris Associates Japan StrategyÂ  Q2 2024 Commentary,https://seekingalpha.com/article/4720404,
SeekingAlpha,"Crown Castle: Attractive, Undervalued Opportunity",https://seekingalpha.com/article/4720221,
